The biological division of SmithKline Beecham Pharma of Toronto is searching for a new agency to replace Kennedy Huggins Marchant Shields.
Two agencies have been short-listed, with a decision expected within days.
Kennedy Huggins resigned the business after a year, citing a possible conflict of interest.
Kevin Kennedy, president of the two-year-old Toronto shop, describes it as a ‘good news, bad news situation.’
His wife, Robin Kennedy, has just been made product manager of SmithKline Beecham’s biological division, which produces hepatitis B vaccine Engerix B, the company’s second-largest product. PS
